Space

More Articles

Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters

SAN JOSE,Calif.,May 23,2024-- Complete Genomics,a pioneering genomic sequencing company,recently welcomed vendors,suppliers,customers and employees to a May 17 grand opening celebration of its 10,115

May 30, 2024

Vatech Partners with Tygerberg Public Hospital to Improve Dental Care in South Africa

SEOUL,South Korea,May 23,2024-- Vatech,a global leader in the dental imaging market,is launching a project to improve dental healthcare in South Africa. Vatech announced today that it has partnered w

May 30, 2024

Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer

SHANGHAI and WARREN,N.J.,May 23,2024--Laekna,Inc. (2105.HK),a science-driven,clinical-stage biotechnology company,announced thatthe company has received approval from the U.S. Food and Drugs Administr

May 30, 2024

EHI AND NBA CHINA ANNOUNCE MULTIYEAR MARKETING PARTNERSHIP

- eHi Becomes the Official Car Rental Services Partner of NBA China - SHANGHAI,May 23,2024-- NBA China and Shanghai eHi Car Rental Co.,Ltd.,announced a multiyear marketing partnership that makes eHi t

May 30, 2024

120 Teams of Young Innovators Shine at the Hong Kong Science Fair

Annual Event Showcases the Power of Creativity and the Innovation of Next Generation Technology in Hong Kong

May 30, 2024

Summit Planners: Unveiling the 5 Common Myths About Will Planning

SINGAPORE,May 24,2024-- There are numerous misconceptions and inaccurate beliefs surrounding Wills.Summit Planners understands that many may lack knowledge when it comes to Will writing,leading to fr

May 30, 2024

Antengene To Present One Oral and Four Abstracts at ASCO 2024

Oral Presentation:a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer

May 30, 2024

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

May 30, 2024

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Antitumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA.

May 30, 2024

Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region

RIYADH,Saudi Arabia,May 24,2024-- Recently in Riyadh,Newrizon,a startup dedicated in electrifying and revolutionizing urban delivery vehicles,signed dealership agreement and intent purchase order with

May 30, 2024

CNFinance to Hold Annual General Meeting on June 7, 2024

GUANGZHOU,China,May 24,2024-- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"),a leading home equity loan service provider inChina,today announced that it will

May 30, 2024

Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform

REDWOOD CITY,Calif.,May 24,2024--Rokidhas announced the launch of its new AR device,the Rokid AR Lite,on Kickstarter,marking the first AR glasses powered by the Snapdragon® 6 Gen 1 Mobile Platform

May 30, 2024

Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News

Singapore Technology Information is an advanced technology news portal. Committed to reporting on the latest developments in technology, artificial intelligence, biotechnology, data and other fields.